Final report of an open-label phase II trial of bevacizumab plus docetaxel and gemcitabine in metastatic, previously untreated nonsquamous non-small cell lung cancer (NSCLC).
Nathan A. Pennell
Disclosure not yet available
Sujith R. Kalmadi
Disclosure not yet available
Marc A. Shapiro
Disclosure not yet available
Hamed Daw
Disclosure not yet available
Cristina P. Rodriguez
Disclosure not yet available
Abdo S. Haddad
Disclosure not yet available
Tara Rich
Disclosure not yet available
Julia Samsa
Disclosure not yet available
Paul Elson
Disclosure not yet available
Patrick C. Ma
Disclosure not yet available
Afshin Dowlati
Disclosure not yet available